GMWatch mythbuster exposes UK government misinformation on gene editing
By GMWatch Staff,
GMWatch
| 02. 16. 2021
UK farm and environment ministry DEFRA published an “Explainer” document on gene editing as a guide for members of the public who want to respond to the UK government’s consultation on its plan to deregulate gene editing. It may also have been meant to assist the media, as parts of the text also occur in DEFRA’s press release for the launch of the public consultation.
Just over three weeks into the consultation the “Explainer” suddenly seemed to disappear from DEFRA’s website, possibly as a result of complaints.
There is certainly plenty to complain about. The “Explainer” is packed full of false assertions and reads like a “wish list” for the GMO lobby, presenting hypothetical “benefits” of gene editing as fact. The Cabinet Office Consultation Principles stipulate that “Consultations should be informative. Give enough information to ensure that those consulted understand the issues and can give informed responses”. They should “include validated impact assessments of the costs and benefits of the options being considered when possible".
But the information presented in the "Explainer" is extremely biased and only presents one side...
Related Articles
By Katie Hunt, CNN | 07.30.2025
Scientists are exploring ways to mimic the origins of human life without two fundamental components: sperm and egg.
They are coaxing clusters of stem cells – programmable cells that can transform into many different specialized cell types – to form...
By Ewen Callaway, Nature | 08.04.2025
For months, researchers in a laboratory in Dallas, Texas, worked in secrecy, culturing grey-wolf blood cells and altering the DNA within. The scientists then plucked nuclei from these gene-edited cells and injected them into egg cells from a domestic dog ...
By Kristel Tjandra, Genetic Engineering & Biotechnology News | 07.30.2025
CRISPR has taken the bioengineering world by storm since its first introduction. From treating sickle cell diseases to creating disease-resistant crops, the technology continues to boast success on various fronts. But getting CRISPR experiments right in the lab isn’t simple...
By Arthur Caplan and James Tabery, Scientific American | 07.28.2025
An understandable ethics outcry greeted the June announcement of a software platform that offers aspiring parents “genetic optimization” of their embryos. Touted by Nucleus Genomics’ CEO Kian Sadeghi, the $5,999 service, dubbed “Nucleus Embryo,” promised optimization of...